Viracta Therapeutics, Inc.·4

Aug 18, 4:46 PM ET

Cohen Darrel P. 4

4 · Viracta Therapeutics, Inc. · Filed Aug 18, 2023

Insider Transaction Report

Form 4
Period: 2023-08-16
Cohen Darrel P.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-08-16+235,000235,000 total
    Exercise: $1.23Exp: 2033-08-16Common Stock (235,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-08-16+265,000265,000 total
    Exercise: $1.23Exp: 2033-08-16Common Stock (265,000 underlying)
Footnotes (2)
  • [F1]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
  • [F2]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION